Glycogen synthase kinase 3 (GSK3) has been tied as a critical factor in the development of multiple major diseases from cancer to Alzheimer’s, but drug development has been stymied by a lack of options to detect GSK3 activity in vivo. We show here that GSK3 activity can be measured accurately in vivo by following the production of glycogen from a single bolus of unlabeled glucose on a standard 3T preclinical imaging system. Imaging of glycogen synthesis was possible at 9.4T by CSI, where it was found in mice to be centered on the olfactory bulb, as expected from post-mortem analysis
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords